The public Defense programme booklet identifies Nolan as the OCRP2011 Teal Innovator. His perspective reports ovarian-cancer cohort classification and describes hoped-for clinical benefits. This documents a public biomedical programme association; it establishes no classified UAP approach or access.
Selected Nolan perspective and programme context readThe 2023 FDA presentation repeats 75F40120C00176 as an FDA/OMHHE collaboration studying COVID-19 illness in diverse populations. It provides a later official account of the same funding relationship described in 2022, rather than a new independent study or award. Nolan’s connection comes from the separate MaxFuse acknowledgement; no classified UAP access is reported.
Partial root native PDF text and selected layout reviewRobert Orr’s FDA presentation publicly describes a 2017 modification of contract HHSF223201610018C and links 75F40120C00176 to a collaboration studying COVID-19 illness in diverse populations. These identifiers match contracts acknowledged for Nolan in MaxFuse. The slides document agency statements about public research funding; they do not name Nolan or establish secret invitations or UAP access.
Partial root native PDF text and selected layout reviewThe presentation discusses material analyses and isotope measurements, with contamination, repeat-analysis and incomplete-value qualifications. Unusual isotope ratios alone do not establish extraterrestrial origin or authenticated custody.
Slide text and static illustrations reviewedAn FDA contract listing names Stanford University for 75F40120C00176, independently of the MaxFuse acknowledgement. The requirement concerns coronavirus research. Its wording differs from a later FDA presentation using the same identifier; the amendment or naming history remains unresolved. This supports a public institutional funding link, without establishing Nolan as the named principal investigator or a classified programme.
Partial root native PDF text and selected layout reviewOfficial NIH metadata returns two FY2021 application records for 3U19AI100627-09S2, both naming Scripps as recipient and the same amount. Their contact PIs are Garry P. Nolan and Richard J. Ulevitch; Sage appears in neither PI list. Shared identifiers and differing dates do not establish two independent awards or their administrative relationship. The paper’s Sage/Nolan support acknowledgement is preserved as a different fact from registered PI metadata. No classified approach, agency adoption or UAP involvement is established.
Official award metadata only; scientific and award bodies unreviewedA curated public selection. Source review describes what was read; it does not establish that a claim is true. Our research approach